IONIS PHARMACEUT reported $293.82M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agios Pharmaceuticals AGIO:US $ 60.65M 35.85M
Alnylam Pharmaceuticals ALNY:US $ 554.65M 59.82M
Arena Pharmaceuticals ARNA:US $ 64.84M 17.33M
Arrowhead Research ARWR:US $ 195.43M 28.25M
Astellas Pharma 4503:JP Y 581580M 10792M
Biomarin Pharmaceutical BMRN:US $ 443.34M 13.31M
Bluebird Bio BLUE:US $ 247.76M 41.45M
Dicerna Pharmaceuticals DRNA:US $ 207.65M 25.5M
Esperion Therapeutics ESPR:US $ 82.64M 15.25M
Exelixis EXEL:US $ 255.33M 41.99M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Halozyme Therapeutics HALO:US $ 114.25M 6.83M
Intercept Pharmaceuticals ICPT:US $ 145.28M 0.95M
Mirati Therapeutics MRTX:US $ 180.87M 103.76M
Moderna Inc MRNA:US 8.84B 399M
Nektar Therapeutics NKTR:US $ 131.02M 7.39M
Neurocrine Biosciences NBIX:US $ 212.9M 22.9M
Novartis NOVN:VX SF 29633M 527M
Omeros OMER:US $ 47.7M 4.26M
Ptc Therapeutics PTCT:US $ 290.96M 40.01M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Sarepta Therapeutics SRPT:US $ 425.02M 60.29M
Ultragenyx Pharmaceutical RARE:US $ 127.07M 0.02M
Vertex Pharmaceuticals VRTX:US $ 1836.45M 107.6M